Wenge Tech, a CAS-owned data analytics business targeting media applications, has attracted Cash Holdings and CAS Star for its latest round.

Sema4, spun out of Icahn School of Medicine, has achieved a valuation of more than $1bn following a $121m series C round.

Co-founded by faculty from Columbia University and University of Melbourne, Praxis Precision Medicines targets CNS disorders.

Chinese Academy of Sciences' Cash Holdings invested with its affiliate fund Guoke Ruihua to aid Shanghai Topgen's biotech development.

The Zhejiang University Future Capital-backed cancer and inflammatory disease drug developer has now raised more than $260m in under two years.

Novo, Pfizer and Nan Fung helped provide $93.5m for the Stanford immunotherapy spinout as it advances its lead asset towards the clinic.

Syncona supplied a third of the investment and retains a majority stake in Freeline, which is based on research at UCL.

Chinese Academy of Sciences-backed laser-diode chip foundry Everbright Photonics has now raised $63.3m since it was founded in 2012.

Hartford Healthcare returned for a $50m series C round that will support the Stanford spinout in advancing potential treatments for severe liver and inflammatory bowel diseases.

Material Impact has participated in a series C1 round for Zero Mass Water, the ASU spinout that has created a system to convert air and sunlight to drinking water.